Har du lyst til å hjelpe oss med å formidle forskning og pasientinformasjon? Vi søker en ny videoprodusent! #ledigstilling#ledigjobb https://t.co/QESyBWAPNw
Thanks to IFI at @unioslo_mn
for the generous invitation to present Andreas Kleppe his AI approach and the efforts to improve cancer diagnostics. @Oslounivsykehus@forskningsradet https://t.co/DPJmhFy3G7
Ny NORA podcast er ute! I denne episoden intervjuer Klas Pettersen og Morten Goodwin Håvard E. Danielsen, leder av Institutt for kreftgenetikk og informatikk ved Oslo Universitetssykehus HF, og prosjektleder for DoMore! https://t.co/GZB8tUsl5s
AI transformation of medical practices can go faster with better design of deep learning studies, according to a Perspective from our ICGI researchers https://t.co/kaLhKy5wil https://t.co/P1bbQA0fvy #deeplearningalgorithms#Cancer#medicine#Domore
Perspective: Better study design will facilitate the development of deep learning systems that could transform current medical practice. Predefine the primary analysis and use more varied training data. What do you reckon, @EricTopol? https://t.co/P1bbQA0fvy @NatureRevCancer
The Institute for Cancer Genetics and Informatics is looking for an employee with knowledge of, and experience with, cytogenetic and molecular cytogenetic (FISH) methods used in genetic cancer diagnostics. #diagnostics https://t.co/RxWpSYvYwC
The Institute of Cancer Genetics and Informatics is looking for an employee with knowledge of, and experience with, cytogenetic and molecular methods used in cancer genetics. The tasks will be linked to research #diagnostics https://t.co/BAwxL8jmC3
A novel marker might contribute to selecting high-risk stage I ovarian carcinoma patients for adjuvant chemotherapy and low-risk endometrial carcinoma patients for less extensive surgery. #cancer#diagnostics#AI#machinelearing https://t.co/7RgcXeKPAY
FANTASTIC NEWS today that we will get a new Novaseq sequencing instrument in the ICR Genomics Core, Division of Cancer Medicine @Oslounivsykehus for research and diagnostics in InPreD to stratify patients to trials like IMPRESS funded by @radiumlegat and @Kreftforeningen
We are so grateful for the support from Radiumhospitalets Legater and the Norwegian Cancer Society - both being major contributors throughout many years supporting research, technology and competence building in Cancer Genomics 🙏🏻 @Kreftforeningen@radiumlegat
Congratulation to Ph.D. fellow Ole-Johan Skrede and his co-writers for receiving one of OUS awards for best research articles in spring of 2020! https://t.co/aNhw1MrXKw
@OsloCancer
@Oslounivsykehus@forskningsradet@Kreftforeningen@Kreftlex